Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H22F3N |
Molecular Weight | 357.412 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C2=CC=CC3=CC=CC=C23
InChI
InChIKey=VDHAWDNDOKGFTD-MRXNPFEDSA-N
InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1
Molecular Formula | C22H22F3N |
Molecular Weight | 357.412 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:21 UTC 2023
by
admin
on
Fri Dec 15 15:45:21 UTC 2023
|
Record UNII |
UAZ6V7728S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2136
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
WHO-VATC |
QH05BX01
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
WHO-ATC |
H05BX01
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
NDF-RT |
N0000020081
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
NDF-RT |
N0000175902
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
163402
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
MIMPARA (AUTHORIZED: HYPERPARATHYROIDISM, PARATHYROID NEOPLASMS, HYPERCALCEMIA)
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
165102
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
511315
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PARAREG (WITHDRAWN: HYPERPARATHYROIDISM, PARATHYROID NEOPLASMS, HYPERCALCEMIA)
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8287
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
DTXSID8048286
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
48390
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
C476217
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
100000089455
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
UAZ6V7728S
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
156419
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
Cinacalcet
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
QQ-71
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
C74100
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
SUB25416
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
7318
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201284
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
3308
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
407990
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | RxNorm | ||
|
647
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
m3555
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | Merck Index | ||
|
UAZ6V7728S
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
226256-56-0
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY | |||
|
DB01012
Created by
admin on Fri Dec 15 15:45:21 UTC 2023 , Edited by admin on Fri Dec 15 15:45:21 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TARGET -> AGONIST | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||